Suven Life shares close 7.5% up on securing molecule patent
The stock surged 7.09 per cent to settle at Rs 252.20 on the BSE. During the day, it jumped 8.66 per cent to Rs 255.90.
By PTI |
MUMBAI: Shares of Suven Life Sciences soared 7.5 per cent today after the company got patent from China, South Africa and Mexico for a molecule used in treating neuro-degenerative diseases.
The stock surged 7.09 per cent to settle at Rs 252.20 on the BSE. During the day, it jumped 8.66 per cent to Rs 255.90.
At the NSE, shares of the company rose by 7.46 per cent to Rs 252.60 at close.
In terms of volume, 4.94 lakh shares of the company changed hands at the BSE while over 23 lakh shares were traded at the NSE during the day.
Neuro-degenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.
In a BSE filing, the company said it "secured patents from China and South Africa to the new chemical entities (NCE) for central nervous system (CNS) therapy".
Meanwhile, in the broader market, the benchmark BSE Sensex ended the day with a gain of 299.79 points at 27,961.19.
The stock surged 7.09 per cent to settle at Rs 252.20 on the BSE. During the day, it jumped 8.66 per cent to Rs 255.90.
At the NSE, shares of the company rose by 7.46 per cent to Rs 252.60 at close.
In terms of volume, 4.94 lakh shares of the company changed hands at the BSE while over 23 lakh shares were traded at the NSE during the day.
Neuro-degenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.
In a BSE filing, the company said it "secured patents from China and South Africa to the new chemical entities (NCE) for central nervous system (CNS) therapy".
ADVERTISEMENT
Meanwhile, in the broader market, the benchmark BSE Sensex ended the day with a gain of 299.79 points at 27,961.19.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
